Exploring the Antineoplastic Potential: A Deep Dive into 7-Xylosyltaxol
At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to advancing scientific understanding and therapeutic innovation. Our focus today is on 7-Xylosyltaxol (CAS 90332-66-4), a compound that holds significant promise in the field of oncology research. As a derivative of Paclitaxel, it inherits a potent antineoplastic activity, making it an invaluable asset for researchers exploring novel cancer treatments.
The exploration of 7-Xylosyltaxol CAS 90332-66-4 antineoplastic activity is a cornerstone for many ongoing research endeavors. Scientists are investigating its mechanisms of action, which are closely related to those of Paclitaxel, involving the disruption of microtubule dynamics essential for cell division. This makes it a key compound in the pursuit of effective anticancer drug discovery. The availability of high-purity pharmaceutical standards like 7-Xylosyltaxol is critical for ensuring the reliability and reproducibility of experimental results.
Our role as a supplier in China is to provide researchers with the high-quality materials they need to push the boundaries of scientific knowledge. The compound's application extends to the development of robust immunoassay development for paclitaxel, allowing for more precise quantification and monitoring in research settings. This precision is paramount when dealing with complex biological samples and for establishing accurate reference ranges.
Furthermore, the broader impact of 7-Xylosyltaxol on pharmaceutical research is substantial. It serves as a vital tool for pharmacological studies, enabling a deeper understanding of cellular responses to cytotoxic agents. By providing access to such specialized compounds, NINGBO INNO PHARMCHEM CO.,LTD. aims to support the global scientific community in its mission to combat diseases and improve patient outcomes. The price of such advanced compounds often reflects their complexity in synthesis and purification, but their value in accelerating research is undeniable.
For institutions and researchers seeking to procure this critical compound, understanding the buy and purchase process is straightforward. Our commitment is to facilitate access to these essential pharmaceutical standards and reference materials, thereby empowering innovation. The consistent quality and availability of 7-Xylosyltaxol from a reliable manufacturer are key factors for successful long-term research projects.
Perspectives & Insights
Chem Catalyst Pro
“, we are dedicated to advancing scientific understanding and therapeutic innovation.”
Agile Thinker 7
“Our focus today is on 7-Xylosyltaxol (CAS 90332-66-4), a compound that holds significant promise in the field of oncology research.”
Logic Spark 24
“As a derivative of Paclitaxel, it inherits a potent antineoplastic activity, making it an invaluable asset for researchers exploring novel cancer treatments.”